World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Chemistry 53 13086 11772 737 653 230 9990

Ian Collins publications per year

The chart shows the history of publications by Ian Collins between 1969 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ian Collins published across 57 years, from 1969 to 2025, averaging 6.2 papers a year. Output peaked at 73 publications in 2023. 5 of the 351 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1969 to 2025. Vertical axis: number of publications, 0 to 73. Peak 73 publications in 2023. 1969: 2 publications 1970: 1 publication 1971: 1 publication 1972: 0 publications 1973: 0 publications 1974: 0 publications 1975: 0 publications 1976: 0 publications 1977: 4 publications 1978: 0 publications 1979: 0 publications 1980: 0 publications 1981: 0 publications 1982: 2 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 2 publications 1992: 1 publication 1993: 3 publications 1994: 8 publications 1995: 4 publications 1996: 3 publications 1997: 3 publications 1998: 7 publications 1999: 6 publications 2000: 6 publications 2001: 5 publications 2002: 2 publications 2003: 5 publications 2004: 9 publications 2005: 11 publications 2006: 13 publications 2007: 28 publications 2008: 16 publications 2009: 19 publications 2010: 20 publications 2011: 15 publications 2012: 5 publications 2013: 13 publications 2014: 9 publications 2015: 6 publications 2016: 11 publications 2017: 6 publications 2018: 6 publications 2019: 7 publications 2020: 4 publications 2021: 3 publications 2022: 7 publications 2023: 73 publications 2024: 2 publications 2025: 3 publications
1969 2025

351 publications in total across all disciplines

View publications per year as a table
Ian Collins: publications per year, 1969 to 2025
Year Publications
1969 2
1970 1
1971 1
1972 0
1973 0
1974 0
1975 0
1976 0
1977 4
1978 0
1979 0
1980 0
1981 0
1982 2
1983 0
1984 0
1985 0
1986 0
1987 0
1988 0
1989 0
1990 0
1991 2
1992 1
1993 3
1994 8
1995 4
1996 3
1997 3
1998 7
1999 6
2000 6
2001 5
2002 2
2003 5
2004 9
2005 11
2006 13
2007 28
2008 16
2009 19
2010 20
2011 15
2012 5
2013 13
2014 9
2015 6
2016 11
2017 6
2018 6
2019 7
2020 4
2021 3
2022 7
2023 73
2024 2
2025 3
Total 351
Download as CSV

Ian Collins publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Ian Collins sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 221–240 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 230 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918
141–160 1,218
161–180 1,350
181–200 1,344
201–220 1,281
221–240 1,216 230
241–260 1,100
261–280 979
281–300 939
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

Ian Collins D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Collins sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 53 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808
46–47 776
48–49 835
50–51 861
52–53 872 53
54–55 933
56–57 1,051
58–59 930
60–61 882
62–63 834
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Overview

Ian Collins is affiliated with PharmEnable Therapeutics in the United Kingdom, contributing significantly to research in the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their work spans multiple subfields including Molecular Biology, Oncology, Computational Theory and Mathematics, Cancer Research, and Electrical and Electronic Engineering.

Their research focuses on key topics such as Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Computational Drug Discovery Methods, Cancer-related Molecular Pathways, Heat shock proteins research, Protein Structure and Dynamics, and NF-κB Signaling Pathways.

Several research papers authored or co-authored by Ian Collins have been published in well-known scientific journals. These papers include:

  • Target 2035 - update on the quest for a probe for every protein, 2021, RSC Medicinal Chemistry
  • CHK1 Inhibition Is Synthetically Lethal with Loss of B-Family DNA Polymerase Function in Human Lung and Colorectal Cancer Cells, 2020, Cancer Research
  • The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use, 2022, Nucleic Acids Research
  • Evolution of kinase polypharmacology across HSP90 drug discovery, 2021, Cell chemical biology
  • SimPLIT: Simplified Sample Preparation for Large-Scale Isobaric Tagging Proteomics, 2022, Journal of Proteome Research

Frequent collaborators in their research include John Caldwell, Rob L. M. van Montfort, Rosemary Burke, Craig McAndrew, and Mark Stubbs, reflecting ongoing partnerships across several projects.

Their scholarly output is also represented in numerous publication venues, with frequent contributions to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • RSC Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • iScience
  • ChemBioChem

Best Publications

  • Macrocycles in new drug discovery

    Jamie Mallinson;Ian Collins

  • 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

    Paul A. Brough;Wynne Aherne;Xavier Barril;Jenifer Borgognoni

  • Normal Human Tissues, in Addition to Some Tumors, Express Multiple Different CD44 Isoforms

    Stephen B. Fox;Jonathan Fawcett;David G. Jackson;Ian Collins

  • Photoaffinity labeling in target- and binding-site identification

    Ewan Smith;Ian Collins

  • Probing the Probes: Fitness Factors For Small Molecule Tools

    Paul Workman;Ian Collins

  • Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response

    Maruf M. U. Ali;Maruf M. U. Ali;Tina Bagratuni;Emma L. Davenport;Piotr R Nowak

  • Measuring and interpreting the selectivity of protein kinase inhibitors

    Lynette A. Smyth;Ian Collins

  • Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

    M. B. Van Niel;I. Collins;M. S. Beer;H. B. Broughton

  • Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.

    Ian Collins;Hannah Wang;John J. Caldwell;Raj Chopra

  • Anxiogenic properties of an inverse agonist selective for α3 subunit-containing GABAA receptors

    John R Atack;Peter H Hutson;Neil Collinson;George Marshall

  • Saturated and unsaturated lactones

    Ian Collins

  • 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels

    Ian Collins;Christopher Moyes;William B Davey;Michael Rowley

  • Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors

    Valerio Berdini;Robert George Boyle;Gordon Saxty;David Winter Walker

  • 5-(4-Chlorophenyl)-4-methyl-3-(1-(2-phenylethyl)piperidin-4-yl)isoxazole: a potent, selective antagonist at human cloned dopamine D4 receptors.

    Rowley M;Broughton Hb;Collins I;Baker R

  • Gamma-secretase inhibitors

    Ian James Collins;Joanne Clare Hannam;Andrew Madin;Mark Peter Ridgill

  • Creating an Antibacterial with in Vivo Efficacy: Synthesis and Characterization of Potent Inhibitors of the Bacterial Cell Division Protein FtsZ with Improved Pharmaceutical Properties

    David J Haydon;JamesM. Bennett;David A. Brown;Ian Collins

  • Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.

    James E. Clifton;Ian Collins;Peter Hallett;David Hartley

  • Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration.

    J.J. Caldwell;T.G. Davies;A. Donald;T. Mchardy

  • A Structural Comparison of Inhibitor Binding to Pkb, Pka and Pka-Pkb Chimera

    Thomas G. Davies;Marcel L. Verdonk;Brent Graham;Susanne Saalau-Bethell

  • Antibacterial alkoxybenzamide inhibitors of the essential bacterial cell division protein FtsZ.

    Lloyd G. Czaplewski;Ian Collins;E. Andrew Boyd;David Brown

  • Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization

    Daniel K. Whelligan;Savade Solanki;Dawn Taylor;Douglas W. Thomson

  • Discovery of 4-Amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides As Selective, Orally Active Inhibitors of Protein Kinase B (Akt)

    Tatiana McHardy;John J. Caldwell;Kwai-Ming Cheung;Lisa J. Hunter

Frequent Co-Authors

Paul Workman
Paul Workman Institute of Cancer Research
Andrew B. Holmes
Andrew B. Holmes University of Melbourne
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Florence I. Raynaud
Florence I. Raynaud Institute of Cancer Research
Suzanne A. Eccles
Suzanne A. Eccles Institute of Cancer Research
Paul D. Leeson
Paul D. Leeson Loughborough University
Laurence H. Pearl
Laurence H. Pearl University of Sussex
Raymond Baker
Raymond Baker MSD (United States)
Edward A. Anderson
Edward A. Anderson University of Oxford
David Barford
David Barford MRC Laboratory of Molecular Biology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career paths across healthcare, pharmaceuticals, and forensic science. Many students explore roles such as pharmacists, where understanding chemistry fundamentals is crucial. To learn more about the educational steps involved, check out this guide on how to become a pharmacist.

For those interested in bridging science and sales, becoming a pharmaceutical sales representative offers an exciting career. This role combines scientific knowledge with communication skills, and insights on compensation and growth can be found in this resource about pharma sales rep salary.

Another specialized field is forensic science, which uses chemistry to aid legal investigations. For students considering online studies, discovering the best online colleges for forensic science can help identify affordable, flexible degree programs.

Additionally, careers like autopsy technician integrate chemistry with medical analysis and pathology. If this path interests you, explore what it takes to pursue this role, including education and job prospects, through the detailed article on autopsy tech.

Best Scientists Citing Ian Collins

Trending Scientists

Recently Published Articles